Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

Astellas Pharma Global Development, Inc. · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
breast-cancernsclconcologyovarian-cancerpancreatic-cancer
advanced solid tumors, nsclc, tumors, squamous cell carcinoma of the head and neck (scchn), oncology, breast cancer, asp1948, mcrpc, ovarian cancer, locally advanced or metastatic solid tumor malignancies, pancreatic cancer, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 889138
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.